Lianlian Fan

No ORCID on file · 2 papers in corpus
nonrandomized-trial 2024
Therapeutic advances in medical oncology ·doi:10.1177/17588359241307818

BACKGROUND: A newly generic microspheres, sustained-release formulation of triptorelin acetate 3.75 mg has been developed. OBJECTIVES: To evaluate the efficacy, pharmacokinetics, and safety of triptorelin 1-month formulation in Chinese pat…

rct 2024
Drug design, development and therapy ·doi:10.2147/dddt.s460681

PURPOSE: Estradiol valerate (Progynova®) is used as hormone therapy to supplement estrogen deficiency. This study aimed to assess the bioequivalence of an estradiol valerate tablet and its generic form, under fasting and fed conditions. ME…